BlossomHill Therapeutics, Inc. (BLSM) stock
BLSMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026
$15.13+1.48 (+10.84%)
Close on Nov 17, 2026Market cap $38.56MP/E –Yield –
BlossomHill Therapeutics total assets
Total assets on the balance sheet at the end of each period.
BlossomHill Therapeutics's total assets was $124.13M at Jun 30, 2026. For fiscal 2025 it was $162.97M.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $162.97M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $124.13M | – |
| Q4 FY2025 | Dec 31, 2025 | $162.97M | – |
See a number that looks wrong?